<DOC>
	<DOCNO>NCT01773486</DOCNO>
	<brief_summary>This study examine whether hesperidin , major component citrus fruit , affect body respond insulin healthy obese people . Laboratory study suggest hesperidin treatment lower blood pressure , lower blood sugar increase blood flow . This study see hesperidin improves insulin resistance insulin 's effect blood flow people insulin resistance . Healthy normal weight overweight people 21 65 year age may eligible study . Participants randomly assign take hesperidin placebo ( inactive dummy pill ) 4-week treatment phase .</brief_summary>
	<brief_title>Effects Hesperidin Insulin Sensitivity</brief_title>
	<detailed_description>This study examine whether hesperidin , major component citrus fruit , affect body respond insulin healthy obese people . Insulin effective people overweight , high blood pressure diabetes . This condition know insulin resistance . Laboratory study suggest hesperidin treatment lower blood pressure , lower blood sugar increase blood flow . This study see hesperidin improves insulin resistance insulin 's effect blood flow people insulin resistance . Healthy normal weight overweight people 21 65 year age may eligible study . Participants randomly assign take hesperidin placebo ( inactive dummy pill ) 4-week treatment phase . In addition treatment , participant undergo follow procedure study period : Screening , include medical history , physical examination blood urine test . Complete dietary physical activity questionnaire consult dietitian Blood urine test At-home clinic blood pressure monitor Glucose clamp test measure body respond insulin . This test do two time study . A needle place vein subject 's arm , one sampling blood infuse insulin , glucose potassium . Glucose insulin level , electrolyte , lipid , fatty acid , cytokine hesperidin level measure . We also use tracer-labeled glucose determine much glucose body produce fast state clamp . This type glucose low level radiation . Forearm blood flow measurement finger plethysmography device . Before begin glucose clamp test , test well blood vessel relax do . A device measure blood flow vessel forefinger use . The test perform glucose clamp test 2 hour begin clamp .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Healthy Subjects Men woman good general health significant underlying illness age 21 65 year age HbA1C &lt; 5.7 % , fast blood glucose &lt; 100 mg/dL , blood pressure less 120/80 , BMI 20 25 kg/m2 . Subjects never smoke tobacco smoke within previous year . Obese Subjects Men woman good general health significant underlying illness except obesity age 21 65 year age HbA1C &lt; 5.7 % , fast blood glucose &lt; 100 mg/dl , blood pressure less 130/90 , BMI 30 45 kg/m2 . Subjects exclude study pregnant , breastfeeding , plan pregnancy prior end study . In addition , subject exclude age &gt; 65 yr , BMI â‰¥ 45 kg/m2 , liver disease ( include liver transaminase level great twice upper limit normal ) , pulmonary disease , renal insufficiency ( serum creatinine great 2.0 mg/dl ) , coronary heart disease , heart failure ( New York Heart Association heart failure Class III IV ) , peripheral vascular disease , coagulopathy , Major depressive disorder , actively smoke use tobacco within last year , history cancer , treatment form cancer , positive test HIV , hepatitis B C , take systemic corticosteroid , thiazolidinediones ( within 3 month ) , insulin , anticoagulant , use food supplement discontinue , regular intake 8 cup tea per week within 3 month prior study entry , regular alcoholic beverage intake two drink per day ( drink corresponds approximately 12 ounce beer , 4 ounce table wine , 1 1.5 ounce 80proof spirit ) , poor compliance runin period regular use medication affect insulin sensitivity , blood pressure vascular function discontinue . In addition , history medical disease , laboratory abnormality , psychological condition would make subject ( base upon principal investigator 's judgment ) unsuitable study enrollment . Subjects exclude unable give inform consent procedure .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Blood pressure</keyword>
</DOC>